Transcatheter aortic valve implantation

Addendum on mode of interventions for aortic stenosis: 2021 ESC/EACTS guidelines indications

Introduction

Surgical aortic valve replacement (SAVR) established in the 1960s has been the only definitive treatment for patients with aortic stenosis (AS) for more than four decades11. Effler DB, Favaloro R, Groves LK. Heart Valve Replacement. Clinical Experience. Ann Thorac Surg. 1965;1:4-24. Link. In 1986, Cribier and colleagues introduced balloon aortic valvuloplasty (BAV) as an alternative treatment for inoperable patients with severe AS22. Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Letac B. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement. Lancet. 1986;1(8472):63-7. Link. Although BAV achieved favourable acute hemodynamic outcomes, restenosis and clinical deterioration occur in most cases within 6-12 months and repeat procedures are frequently needed3, 43. Litvack F, Jakubowski AT, Buchbinder NA, Eigler N. Lack of sustained clinical improvement in an elderly population after percutaneous aortic valvuloplasty. Am J Cardiol. 1988;62(4):270-5. Link4. Lieberman EB, Bashore TM, Hermiller JB, Wilson JS, Pieper KS, Keeler GP, Pierce CH, Kisslo KB, Harrison JK, Davidson CJ. Balloon aortic valvuloplasty in adults: failure of...